Clinical Trial Update: Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine [Phase 1]

View source ↗

Summary

This Phase I trial from Dalhousie University evaluated the safety, tolerability, and immunogenicity of an Ebola virus vaccine; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Snippet

Sponsor: Dalhousie University | Conditions: Ebola Viruses | Phase 1 | Status: COMPLETED